Uscom Limited chart

Last update: 2021-02-19
Key statistics and financials
Revenue per share 0.02
Dividend & YieldN/A$ (N/A)
Beta -0.68
Market capitalization 13.51M
Operating cash flow -967.51k
ESG Scores unknown

Company description

Uscom Limited designs, develops, manufactures, and markets non-invasive cardiovascular and pulmonary medical devices worldwide. It offers USCOM 1A, a non-invasive hemodynamic monitor that measures cardiovascular function using Doppler ultrasound; BP+, a supra-systolic oscillometric central blood pressure monitor that measures blood pressure and blood pressure waveforms at the heart, as well as in the arm; and SpiroSonic, a pulmonary function testing device based on multi-path ultrasound technology. The company also provides the SpiroSonic AIR, a digital multipath ultrasonic spirometer with a viral disinfection system for the elimination of COVID and tuberculosis; and respiratory devices. It serves hospitals and other medical care locations through a network of distribution partners. The company was formerly known as Uscom Pty Limited and changed its name to Uscom Limited in October 2003. The company was incorporated in 1999 and is headquartered in Sydney, Australia.

Sector: Healthcare - Industry: Medical Devices

Financial data

Financial Statements

Cashflow Statement 2019-06-30 2020-06-30 2021-06-30 2022-06-30
Change To Liabilities 184.78k 273.56k 34.76k -19.52k
Total Cashflows From Investing Activities -111.83k -38.16k -33.35k -115.31k
Net Borrowings -236.78k -236.78k -271k -255.31k
Total Cash From Financing Activities 46.23k 796.77k -281.87k 4.05M
Change To Operating Activities -16.76k -6.44k -15.12k 55.77k
Issuance Of Stock 50k 1.05M 4.36M 4.36M
Net Income -1.39M -1.33M -924.24k -1.97M
Change In Cash -1.29M 712.16k -210.1k 2.99M
Effect Of Exchange Rate -13.19k -13.19k 50.14k 27.56k
Total Cash From Operating Activities -1.22M -33.26k 54.98k -967.51k
Depreciation 334.67k 569.73k 395.41k 414.04k
Change To Account Receivables -334.02k 311.55k 46.73k 4.38k
Other Cashflows From Financing Activities -3.77k -16.45k -10.87k -54.86k
Change To Netincome 36.36k 463.36k 583.47k 525.76k
Capital Expenditures -68.53k -15.75k -5.51k -5.83k

Income Statement 2019-06-30 2020-06-30 2021-06-30 2022-06-30
Research Development
Income Before Tax -1.38M -1.31M -882.2k -1.94M
Net Income -1.39M -1.33M -924.24k -1.97M
Selling General Administrative 4.33M 4.84M 4.86M 4.77M
Gross Profit 2.95M 3.85M 4.07M 2.91M
Ebit -1.38M -993.11k -786.69k -1.86M
Operating Income -1.38M -993.11k -786.69k -1.86M
Interest Expense -1.46k -89.9k -95.51k -78.72k
Income Tax Expense 8.46k 17.15k 42.04k 32.44k
Total Revenue 3.64M 4.28M 4.55M 3.25M
Cost Of Revenue 687.25k 435.01k 485.07k 344.47k
Total Other Income ExpenseNet -1.46k -321.08k -95.51k -78.72k
Net Income From Continuing Ops -1.39M -1.33M -924.24k -1.97M
Net Income Applicable To Common Shares -1.39M -1.33M -924.24k -1.97M

Balance Sheet Statement 2019-06-30 2020-06-30 2021-06-30 2022-06-30
Total Liabilities 650.99k 2.5M 2.26M 2.06M
Total Stockholder Equity 3.49M 3.42M 3.08M 5.94M
Other Current Liabilities 123.86k 147.75k 245.42k 208.67k
Total Assets 4.14M 5.92M 5.33M 7.99M
Common Stock 33.3M 34.2M 34.67M 39.14M
Other Current Assets
Retained Earnings -32.68M -34.02M -34.94M -36.91M
Treasury Stock 2.87M 3.24M 3.35M 3.71M
Cash 1.21M 1.92M 1.71M 4.7M
Total Current Liabilities 612.99k 998.42k 948.84k 896k
Other Stockholder Equity 2.87M 3.24M 3.35M 3.71M
Property, Plant, and Equipment 212.82k 1.65M 1.33M 1.12M
Total Current Assets 2.87M 3.68M 3.45M 6.31M
Net Tangible Assets 2.52M 2.92M 2.61M 5.45M
Net Receivables 1.09M 928.81k 845.65k 735.78k
Accounts Payable 282.26k 269.89k 135.58k 153.69k


Insider Transactions

Here are the insider transactions of stock shares related to Uscom Limited:

Filer Name Transaction Text Ownership Date Filer Relation Shares
Phillips (Robert Allan)D2022-07-05Chairman of the Board1.64M
Meng (Xianhui)Acquisition at price 0.08 per share.D2021-12-16Director (Non-Executive)9.88M
Phillips (Robert Allan)Acquisition at price 0.08 per share.D2021-12-16Chairman of the Board9.66M
Phillips (Robert Allan)D2021-07-05Chairman of the Board1.44M
Schicht (Nicholas)D2021-06-30General Manager414.94k
Phillips (Robert Allan)Purchase at price 0.13 per share.D2021-06-29Chairman of the Board165.58k
Phillips (Robert Allan)Purchase at price 0.12 per share.D2021-06-28Chairman of the Board644.63k
Meng (Xianhui)Purchase at price 0.14 per share.D2021-05-26Director (Non-Executive)492.29k
Meng (Xianhui)Purchase at price 0.11 per share.D2021-05-25Director (Non-Executive)1M
Crowley (Brett)Purchase at price 0.14 per share.D2020-12-09Director200k
Phillips (Robert Allan)D2020-10-29Chairman of the Board3.09M
Schicht (Nicholas)D2020-06-30General Manager5k
Meng (Xianhui)Purchase at price 0.15 per share.D2020-05-22Director (Non-Executive)544.56k
Phillips (Robert Allan)D2020-01-10Chairman of the Board3.36M
Phillips (Robert Allan)D2019-07-31Chairman of the Board5k
Schicht (Nicholas)D2018-06-30General Manager100k
Phillips (Robert Allan)Purchase at price 0.13 per share.D2018-06-06Chairman of the Board7k
He (David Chao Xian)D2018-05-23Former205.8k
Phillips (Robert Allan)D2018-01-08Chairman of the Board636.36k
He (David Chao Xian)D2017-12-07Director205.8k
Phillips (Robert Allan)D2017-12-07Chairman of the Board1.5M
Phillips (Robert Allan)D2016-12-23Chairman of the Board3.27M
Phillips (Robert Allan)Exercise at price 0.05 per share.D2016-08-18Chairman of the Board500k
Phillips (Robert Allan)Exercise at price 0.04 per share.D2015-09-30Chairman of the Board500k
Jack (Sheena Gae)Other at price 0.11 per share.D2015-08-21Director (Non-Executive)3.33k
Phillips (Robert Allan)Other at price 0.11 per share.D2015-08-21Chairman of the Board33.33k
Schicht (Nicholas)D2015-06-30General Manager200k
Jack (Sheena Gae)Other at price 0.14 per share.D2013-11-14Director (Non-Executive)166.67k
Jack (Sheena Gae)Other at price 0.21 per share.D2013-03-15Director (Non-Executive)200k
Jack (Sheena Gae)Other at price 0.12 per share.D2012-11-07Director (Non-Executive)350k
Phillips (Robert Allan)Purchase at price 0.18 per share.D2012-09-13Chairman of the Board50k
Fah (Daniel)D2012-06-30Former5k
Johnson (Debra)D2012-06-30Former5.1k
Rathie (Bruce)D2011-08-30Former93.81k
Johnson (Debra)D2011-06-30Divisional Officer5.1k
Kiely (Philip Milton)Other at price 0.30 per share.D2011-03-07Chairman of the Board333.33k
Rathie (Bruce)Acquisition at price 0.30 per share.D2011-02-18Director (Non-Executive)25k
Phillips (Robert Allan)D2011-01-25Chief Executive Officer3.23k
Zwolenski (Roman)D2010-12-22Retired248.81k
Phillips (Robert Allan)Purchase at price 0.23 per share.D2010-09-24Chairman of the Board20k
Schicht (Nicholas)D2010-06-30General Manager500
Butler (Paul William)D2009-12-31Former41.21k
Butler (Paul William)Other at price 0.60 per share.D2009-10-02Chief Executive Officer3k
Phillips (Robert Allan)Other at price 0.55 per share.D2009-10-02Chairman of the Board47.62k
Rathie (Bruce)Other at price 0.55 per share.D2009-10-02Director (Non-Executive)23.81k
Zwolenski (Roman)Other at price 0.55 per share.D2009-10-02Director (Non-Executive)23.81k
Butler (Paul William)Purchase at price 0.23 per share.D2008-12-22Chief Executive Officer5k
Phillips (Robert Allan)Other at price 0.23 per share.D2008-12-22Chairman of the Board20k
Rathie (Bruce)Purchase at price 0.25 per share.D2008-09-03Director (Non-Executive)20k
Schicht (Nicholas)D2008-06-30General Manager10k
Phillips (Robert Allan)Other at price 0.19 per share.D2008-06-27Chairman of the Board22.35k

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to Uscom Limited. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on Uscom Limited

Here is the result of two systematic investment strategies applied to Uscom Limited. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on Uscom Limited

The following chart shows the equity curve of the two systematic investment strategies applied to Uscom Limited:

Uscom Limited automated entries

The systematic investment strategy that buys the first day of the month would give a performance of -3.72% on the backtest period.

Performance at glance

Performance

-3.72 %

Latent gain

-102.18 $

Invested capital

2750.27 $

Annualized return

-0.77 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on Uscom Limited

This is the result of two momentum investment strategies applied to Uscom Limited. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on Uscom Limited

The following chart shows all the entries opened by the momentum investment system on Uscom Limited:

Uscom Limited momentum entries
  • The first momentum investment strategy would give 2.7% of return on Uscom Limited. That represents 215.67$ of latent gain with 8000.26$ of employed capital.
  • The second momentum investment strategy would give 3.09% of return on Uscom Limited. That represents 193.22$ of latent gain with 6249.95$ of employed capital.
Performance at glance (1Q Momentum)

Performance

2.7 %

Latent gain

215.67 $

Invested capital

8000.26 $

Annualized return

13.27 %
Performance at glance (2Q Momentum)

Performance

3.09 %

Latent gain

193.22 $

Invested capital

6249.95 $

Annualized return

0.71 %

Momentum equity curve on Uscom Limited

The following chart shows the equity curve of the two momentum strategies applied to Uscom Limited:

Uscom Limited momentum equity

Note: the dividends potentially given by Uscom Limited are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Uscom Limited

The following chart shows the employed capital evolution of the two momentum strategies on Uscom Limited since the beginning:

Uscom Limited

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Buy the dip strategy result on Uscom Limited

Buy the dip entry openings on Uscom Limited

Uscom Limited

The performance achieved by the robo-advisor on Uscom Limited is 37.42%. That represents 280.68$ of latent gain with 750.03$ of employed capital. The following chart shows Uscom Limited stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of Uscom Limited, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

37.42 %

Latent gain

280.68 $

Invested capital

750.03 $

Annualized return

13.27 %

Equity curve of the strategy applied to Uscom Limited

The following chart shows the result of the investment strategy applied to Uscom Limited:

Uscom Limited

Note: the dividends potentially given by Uscom Limited are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Uscom Limited

The following chart shows the employed capital evolution since the beginning of the investment strategy on Uscom Limited:

Uscom Limited

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on Uscom Limited

In this section, I will compare the three previous investment strategies applied to Uscom Limited.

Equity curve comparison on Uscom Limited

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

Uscom Limited investment strategy comparison

Employed capital comparison on Uscom Limited

Uscom Limited investment comparison

Performance comparison on Uscom Limited

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment -3.72% -102.18$ 2750.27$ -0.77%
Momentum 1 quarter 2.7% 215.67$ 8000.26$ 0.59%
Momentum 2 quarters 3.09% 193.22$ 6249.95$ 0.71%
Non-directional 37.42% 280.68$ 750.03$ 13.27%
Annualized return comparison

Automatic investment

-0.77 %

Momentum 1Q

0.71 %

Momentum 2Q

0.71 %

Non-directional

13.27 %

Correlated stocks

Here are the most positively and negatively correlated stocks with Uscom Limited:

Positive correlations

Most correlated stocks this year


Most correlated stocks last 3 months

Negative correlation

Most negatively correlated stocks this year


Most negatively correlated stocks last 3 months

Note: The algorithm computes the probability of correlation between Uscom Limited and the other stocks. There may be false positives or some missing correlated stocks. If the price of Uscom Limited does not vary for 36 weeks, the correlation calculation result will be wrong.


Company information

Company name Uscom Limited
Country Australia
City Sydney
Address 66 Clarence Street
Phone 61 2 9247 4144
Website www.uscom.com.au
FullTime employees
Industry Medical Devices
Sector Healthcare
Exchange XASX
Ticker UCM.XASX
Market www2.asx.com.au

Uscom Limited ESG Scores

Environment scores

Environment ESG Factors Scores
Environment Score 0
Peer Environment Performance unknown
Environment Percentile unknown
Palm Oil unknown
Nuclear unknown
Fur Leather unknown
GMO unknown
Coal unknown
Pesticides unknown
Animal Testing unknown

Social scores

Social ESG Factors Scores
Social Score 0
Peer Social Performance unknown
Social Percentile unknown
Highest Controversy unknown
Peer Highest Controversy Performance unknown
Adult unknown
Gambling unknown
Alcoholic unknown
Tobacco unknown
Catholic unknown
Controversial Weapons unknown
Small Arms unknown
Military Contract unknown
Peer Count unknown

Related Controversy:


Governance scores

Governance ESG Factors Scores
Governance Score 0
Peer Governance Performance unknown
Governance Percentile unknown

ESG at glance
Total ESG Scores: unknown
Environment Score: 0
Social Score: 0
Governance Score: 0

ESG Performance: unknown

Peer Group: unknown

Peer Esg Score Performance: unknown

Rating Year: unknown

Rating Month: unknown

Max Age: unknown

Percentile: unknown